USFDA grants Breakthrough Designation for blood test to help diagnose...
Datar Cancer Genetics (DCG) has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its ‘TriNetra-Glio’, a blood test to help in the diagnosis of brain...

